Specialised clinic to offer regular device monitoring, battery assessment, rhythm evaluation, and expert cardiac electrophysiology consultation
The high-performance polymer’s transparency and biocompatibility support precise implantation and long-term reliability
Abbott's first-of-its-kind i2i technology enables synchronized communication between two leadless pacemakers
GlobalData predicts the average prices of dual chamber pacemakers in both India and China are expected to reduce at an average CAGR of -3.42% from 2022 to 2025.
Aveir VR is specifically designed to be retrieved when therapy needs to evolve or the device needs to be replaced
The medical team led by Dr. Babu Ezhumalai implanted the dual-chamber leadless pacemaker through a non-surgical procedure successfully
Proprietary implant-to-implant (i2i) device technology is used for communication between two implanted leadless pacemakers to regulate the heart rate
Additional data from APPRAISE ATP trial reinforce modular therapy approach
Singapore presents great opportunities for the adoption of technology in healthcare and is open for investments
Dr Sai Satish, Sr. Consultant Interventional Cardiologist performs India’s first 3 successful G4-Transcatheter Edge to Edge (G4–TEER) mitral valve repairs
Subscribe To Our Newsletter & Stay Updated
